Xeomin Related Published Studies
Well-designed clinical trials related to Xeomin (Botulinum Toxin Type A)
Effectiveness of type A botulinum toxins for aesthetic indications and their
relative economic impact. [2012]
Anticholinergic therapy vs. onabotulinumtoxina for urgency urinary incontinence. [2012]
Botulinum toxin effects on gasatrocnemius strength and plantar pressure in
diabetics with peripheral neuropathy and forefoot ulceration. [2012]
Modification of altered ankle motor control after stroke using focal application
of botulinum toxin type A. [2012]
Vandetanib: in medullary thyroid cancer. [2012]
Botulinum toxin injection for hypertonicity of the upper extremity within 12
weeks after stroke: a randomized controlled trial. [2012]
Immunoresistance in cervical dystonia patients after treatment with
abobotulinumtoxinA. [2012]
Botulinum toxin a versus placebo for refractory detrusor overactivity in women: a
randomised blinded placebo-controlled trial of 240 women (the RELAX study). [2012]
Prospective randomized comparison of onabotulinumtoxinA (Botox) and
abobotulinumtoxinA (Dysport) in the treatment of forehead, glabellar, and
periorbital wrinkles. [2012]
Topical diltiazem cream versus botulinum toxin a for the treatment of chronic
anal fissure: a double-blind randomized clinical trial. [2012]
An early botulinum toxin A treatment in subacute stroke patients may prevent a disabling finger flexor stiffness six months later: a randomized controlled trial. [2011.10.04]
Efficacy and safety of incobotulinumtoxinA (NT 201, XEOMIN(R), botulinum neurotoxin type A, without accessory proteins) in patients with cervical dystonia. [2011.09.15]
A phase III extension trial with a 1-arm crossover from leuprolide to degarelix: comparison of gonadotropin-releasing hormone agonist and antagonist effect on prostate cancer. [2011.09]
Botulinum toxin injection for management of thoracic outlet syndrome: a double-blind, randomized, controlled trial. [2011.09]
Botulinum toxin type-A in the prophylactic treatment of medication-overuse headache: a multicenter, double-blind, randomized, placebo-controlled, parallel group study. [2011.08]
Efficacy and safety of incobotulinumtoxinA (NT 201, Xeomin) in the treatment of blepharospasm-A randomized trial. [2011.07]
Further enhancement of facial appearance with a hydroquinone skin care system plus tretinoin in patients previously treated with botulinum toxin Type A. [2011.07]
Botulinum toxin type A on oral health in treating sialorrhea in children with cerebral palsy: a randomized, double-blind, placebo-controlled study. [2011.07]
Efficacy of botulinum toxin A injection for neurogenic detrusor overactivity and urinary incontinence: a randomized, double-blind trial. [2011.06]
[Treatment of crow's feet with two different botulinum toxin type A preparations in split-face technique]. [2011.05]
Botulinum Toxin for the Upper Limb after Stroke (BoTULS) Trial: effect on impairment, activity limitation, and pain. [2011.05]
Onabotulinum toxin A treatment of cervicogenic headache: a randomised, double-blind, placebo-controlled crossover study. [2011.05]
Urodynamic results and clinical outcomes with intradetrusor injections of onabotulinumtoxinA in a randomized, placebo-controlled dose-finding study in idiopathic overactive bladder. [2011.04]
Effects of botulinum toxin A in ambulant adults with spastic cerebral palsy: a randomized double-blind placebo controlled-trial. [2011.03]
Botulinum toxin A versus B in sialorrhea: a prospective, randomized, double-blind, crossover pilot study in patients with amyotrophic lateral sclerosis or Parkinson's disease. [2011.02.01]
Double-blind, randomised, parallel group pilot study comparing two botulinum toxin type A products for the treatment of blepharospasm. [2011.02]
Functional electrical stimulation combined with botulinum toxin type A to improve hand function in children with spastic hemiparesis - a pilot study. [2011.02]
Botulinum toxin A injections do not improve surface EMG patterns during gait in children with cerebral palsy--a randomized controlled study. [2011.02]
A pilot study of botulinum toxin A for male chronic pelvic pain syndrome. [2011.02]
[Botulinum toxin and painful peripheral neuropathies: what should be expected?]. [2011.01]
Prophylactic botulinum type A toxin complex (Dysport(R)) for migraine without aura. [2011.01]
A multi-center double-blind pilot comparison of onabotulinumtoxinA and topiramate for the prophylactic treatment of chronic migraine. [2011.01]
Long-term efficacy and respective potencies of botulinum toxin A and B: a randomized, double-blind study. [2011.01]
Is it always necessary to apply botulinum toxin into the lower facial muscles in hemifacial spasm?: a randomized, single-blind, crossover trial. [2011]
Implications of current clinical trials focused on medication overuse and
therapeutic prophylaxis. [2011]
Time to onset of response of abobotulinumtoxina in the treatment of glabellar
lines: a subset analysis of phase 3 clinical trials of a new botulinum toxin type
A. [2011]
The safety and efficacy of botulinum toxin-A in the management of bladder
oversensitivity: a randomised double-blind placebo-controlled trial. [2011]
Efficacy of botulinum toxin type A for treatment of persistent myofascial TMD
pain: a randomized, controlled, double-blind multicenter study. [2011]
[Botulinum toxin and painful peripheral neuropathies: what should be expected?]. [Article in French] [2011]
Prophylactic botulinum type A toxin complex (Dysport®) for migraine without aura. [2011]
Dose response with onabotulinumtoxinA for post-stroke spasticity: a pooled data
analysis. [2011]
Noninferiority of incobotulinumtoxinA, free from complexing proteins, compared with another botulinum toxin type A in the treatment of glabellar frown lines. [2010.12]
Multicenter, randomized, parallel-group study of the safety and effectiveness of onabotulinumtoxinA and hyaluronic acid dermal fillers (24-mg/ml smooth, cohesive gel) alone and in combination for lower facial rejuvenation. [2010.12]
Comparison of two botulinum toxin type A preparations for treating crow's feet: a split-face, double-blind, proof-of-concept study. [2010.12]
Efficacy and safety evaluation of a novel botulinum toxin topical gel for the treatment of moderate to severe lateral canthal lines. [2010.12]
Facial rejuvenation after intradermal botulinum toxin: is it really the botulinum toxin or is it the pricks? [2010.12]
Subcutaneous injection of botulinum toxin a is beneficial in postherpetic neuralgia. [2010.12]
Multicenter, randomized, parallel-group study of onabotulinumtoxinA and hyaluronic acid dermal fillers (24-mg/ml smooth, cohesive gel) alone and in combination for lower facial rejuvenation: satisfaction and patient-reported outcomes. [2010.12]
A double-blind, randomized, placebo-controlled health-outcomes survey of the effect of botulinum toxin type a injections on quality of life and self-esteem. [2010.12]
Efficacy and safety of onabotulinumtoxinA for idiopathic overactive bladder: a double-blind, placebo controlled, randomized, dose ranging trial. [2010.12]
Botulinum toxin-A injections into neurogenic overactive bladder--to include or exclude the trigone? A prospective, randomized, controlled trial. [2010.12]
Comparison of treatment of melomental fold rhytides with cross-linked hyaluronic acid combined with onabotulinumtoxina and cross-linked hyaluronic acid alone. [2010.11]
Evaluating the effects of ice application on patient comfort before and after botulinum toxin type A injections. [2010.10]
Botulinum toxin type A in post-stroke upper limb spasticity. [2010.08]
Botulinum neurotoxin-A does not spread to distant muscles after intragastric injection: A double-blind single-fiber electromyography study. [2010.08]
Randomized trial of botulinum toxin to prevent pes cavus progression in pediatric charcot-marie-tooth disease type 1A. [2010.08]
Botulinum toxin type A in post-stroke lower limb spasticity: a multicenter, double-blind, placebo-controlled trial. [2010.08]
Botulinum toxin A treatment in toddlers with cerebral palsy. [2010.08]
Comparison between botulinum toxin and corticosteroid injection in the treatment of acute and subacute tennis elbow: a prospective, randomized, double-blind, active drug-controlled pilot study. [2010.08]
Botulinum toxin type A versus amitriptyline for the treatment of chronic daily migraine. [2010.07]
Intravesical injections of botulinum toxin type A for management of neuropathic bladder: a comparison of two methods. [2010.07]
Long-term efficacy and safety of botulinum toxin type A (Dysport) in cervical dystonia. [2010.06]
Use of anatomic measurement to guide injection of botulinum toxin for the management of chronic lateral epicondylitis: a randomized controlled trial. [2010.05.18]
[Clinical research of electroacupuncture combined with acupoint-injection of botulinum toxin A in treating the muscle spasticity by spinal cord injury] [2010.05]
Cyclic functional electrical stimulation does not enhance gains in hand grasp function when used as an adjunct to onabotulinumtoxinA and task practice therapy: a single-blind, randomized controlled pilot study. [2010.05]
A double-blind, controlled, randomized trial to evaluate the efficacy of botulinum toxin for the treatment of lumbar myofascial pain in humans. [2010.05]
Effect of addition of botulinum toxin-A to standardized therapy for dynamic manual skills measured with kinematic aiming tasks in children with spastic hemiplegia. [2010.04]
Efficacy of intra-articular botulinum toxin type A in painful knee osteoarthritis: a pilot study. [2010.04]
Botulinum toxin, physical and occupational therapy, and neuromuscular electrical stimulation to treat spastic upper limb of children with cerebral palsy: a pilot study. [2010.03]
Diode laser hair removal does not interfere with botulinum toxin A treatment against axillary hyperhidrosis. [2010.03]
Botulinum toxin type A versus phenol. A clinical and neurophysiological study in the treatment of ankle clonus. [2010.03]
Repeated injections of botulinum toxin-A for idiopathic detrusor overactivity. [2010.03]
Bilateral versus posterior injection of botulinum toxin in the internal anal sphincter for the treatment of acute anal fissure. [2010.02]
Ultrasonographic guided botulinum toxin type A treatment for plantar fasciitis: an outcome-based investigation for treating pain and gait changes. [2010.02]
Prospective randomized evaluation of periureteral botulinum toxin type A injection for ureteral stent pain reduction. [2010.02]
Prospective, randomized, double-blind study, comparing botulinum toxins type a botox and prosigne for blepharospasm and hemifacial spasm treatment. [2010.01]
Goal attainment scaling in the evaluation of treatment of upper limb spasticity with botulinum toxin: a secondary analysis from a double-blind placebo-controlled randomized clinical trial. [2010.01]
Effect of botulinum toxin injection on nocturnal bruxism: a randomized controlled trial. [2010.01]
Combined botulinum toxin type A with modified constraint-induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled study. [2010.01]
Botulinum toxin type A for the treatment of glabellar lines in Chinese: a double-blind, randomized, placebo-controlled study. [2010]
Urodynamic effects of once daily tadalafil in men with lower urinary tract
symptoms secondary to clinical benign prostatic hyperplasia: a randomized,
placebo controlled 12-week clinical trial. [2010]
The role of kinesiotaping combined with botulinum toxin to reduce plantar flexors
spasticity after stroke. [2010]
OnabotulinumtoxinA for treatment of chronic migraine: results from the
double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. [2010]
OnabotulinumtoxinA for treatment of chronic migraine: results from the
double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial. [2010]
Botulinum toxin A for treatment of allodynia of complex regional pain syndrome: a
pilot study. [2010]
Botulinum toxin type A in post-stroke upper limb spasticity. [2010]
OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the
double-blind, randomized, placebo-controlled phases of the PREEMPT clinical
program. [2010]
Botulinum toxin type A in post-stroke lower limb spasticity: a multicenter,
double-blind, placebo-controlled trial. [2010]
Diode laser hair removal does not interfere with botulinum toxin A treatment
against axillary hyperhidrosis. [2010]
Goal attainment scaling in the evaluation of treatment of upper limb spasticity
with botulinum toxin: a secondary analysis from a double-blind placebo-controlled
randomized clinical trial. [2010]
Repeated injections of botulinum toxin-A for idiopathic detrusor overactivity. [2010]
Supraciliary wrinkles and botulinum toxin A. [2010]
Clinical efficacy and tolerability of Xeomin in the treatment of blepharospasm. [2009.12]
Long lasting benefits following the combination of static night upper extremity splinting with botulinum toxin A injections in cerebral palsy children. [2009.12]
Blinded randomized clinical trial of botulinum toxin versus isosorbide dinitrate ointment for treatment of anal fissure. [2009.12]
An analysis of safety data from five phase III clinical trials on the use of botulinum neurotoxin type A-ABO for the treatment of glabellar lines. [2009.11]
Minimally invasive application of botulinum toxin A in patients with idiopathic rhinitis. [2009.10.16]
A single-center dose-comparison study of botulinum neurotoxin type A in females with upper facial rhytids: assessing patients' perception of treatment outcomes. [2009.10]
Efficacy and safety of botulinum toxin type A in the treatment of lateral crow's feet: double-blind, placebo-controlled, dose-ranging study. [2009.10]
Effect of Botulinum Toxin Injection on Nocturnal Bruxism: A Randomized Controlled Trial. [2009.09.26]
Efficacy and safety of botulinum neurotoxin NT 201 in poststroke upper limb spasticity. [2009.09]
|
